Gyre Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -105.4% | -105.4% | -44.5% |
| FY2017 | -70.1% | -70.1% | -54.6% |
| FY2018 | -25.1% | -25.1% | -24.1% |
| FY2019 | -80.7% | -80.7% | -56.0% |
| FY2020 | -73.9% | -73.9% | -59.3% |
| FY2021 | -214.0% | -214.0% | -158.0% |
| FY2022 | 10.1% | 10.1% | 5.1% |
| FY2023 | 540.1% | 540.1% | -73.3% |
| FY2024 | 28.3% | 28.3% | 14.3% |
| FY2025 | 9.3% | 9.3% | 5.9% |